Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers Diabetes Mellitus, Type 2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05491421
What this trial is testing

ZT002 in Healthy Participants

Who this might be right for
Type 2 Diabetes Mellitus
QL Biopharmaceutical Australia Pty Ltd 32
Early research (Phase 1)UnknownNCT03565458
What this trial is testing

Gemigliptin, Dapagliflozin, Empagliflozin DDI Study

Who this might be right for
Type 2 Diabetes Mellitus
LG Chem 48
Early research (Phase 1)Study completedNCT01508858
What this trial is testing

Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 21
Early research (Phase 1)Study completedNCT01183715
What this trial is testing

A Single Dose Study Of PF-05161704 In Healthy Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 18
Early research (Phase 1)Study completedNCT06948747
What this trial is testing

Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 49
Early research (Phase 1)Study completedNCT01607385
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 56
Early research (Phase 1)Study completedNCT06555822
What this trial is testing

Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 31
Early research (Phase 1)Study completedNCT04907019
What this trial is testing

A Drug Interaction Study of SY-004 Capsules in Healthy Subjects

Who this might be right for
Type 2 Diabetes
Suzhou Yabao Pharmaceutical R&D Co., Ltd. 24
Not applicableUnknownNCT02025673
What this trial is testing

Study of Betatrophin Levels in Patients With Type 2 Diabetes and Gestational Diabetes and Healthy Subjects

Who this might be right for
PregnancyGestational Diabetes Mellitus (GDM)Type 2 Diabetes
Qingdao University 200
Early research (Phase 1)Study completedNCT06883656
What this trial is testing

The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Renal Insuficiency
Shenzhen Salubris Pharmaceuticals Co., Ltd. 18
Not applicableStudy completedNCT07646015
What this trial is testing

Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders

Who this might be right for
Diabetes Mellitus, Type 2Liver DiseasesKidney Diseases+3 more
Respyr 3,000
Early research (Phase 1)Study completedNCT03745885
What this trial is testing

The Efficacy and Safety of Supaglutide in Healthy Participants

Who this might be right for
Diabetes Mellitus, Type 2
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 48
Early research (Phase 1)Study completedNCT00532610
What this trial is testing

Compare the Effect on Heart Rhythm of 3 Days of GSK189075, Placebo, or Moxifloxacin in Healthy Adults

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
GlaxoSmithKline 78
Early research (Phase 1)Study completedNCT04142424
What this trial is testing

Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Who this might be right for
Metabolic DisordersNon-alcoholic Steatohepatitis
AstraZeneca 73
Early research (Phase 1)UnknownNCT05642377
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Glaceum 40
Early research (Phase 1)Study completedNCT01089166
What this trial is testing

Study to Compare the Bioavailability of Extended Release Metformin HCl Tablet Versus Glucophage XR® Tablets in Healthy Human Volunteers Under Fasting Condition

Who this might be right for
Type 2 Diabetes
Torrent Pharmaceuticals Limited
Early research (Phase 1)Study completedNCT06654960
What this trial is testing

Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Study completedNCT05549583
What this trial is testing

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers

Who this might be right for
BioequivalenceType 2 Diabetes
Galenicum Health 26
Very early researchLooking for participantsNCT06609356
What this trial is testing

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusGlucokinase-Maturity Onset Diabetes of the Young (GCK-MODY)MODY2 Diabetes+1 more
Vanderbilt University Medical Center 27
Early research (Phase 1)Ended earlyNCT01068756
What this trial is testing

Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 14
Next Page